Viewing Study NCT00542893


Ignite Creation Date: 2025-12-25 @ 1:12 AM
Ignite Modification Date: 2026-01-05 @ 10:50 PM
Study NCT ID: NCT00542893
Status: COMPLETED
Last Update Posted: 2012-03-13
First Post: 2007-10-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine
Sponsor: Genta Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module